DURHAM, NC--(Marketwire - January 23, 2008) - Aldagen, Inc., a biotechnology company advancing a pipeline of clinical-stage regenerative therapies, today announced that W. Thomas Amick, Chairman and CEO of Aldagen, will be presenting at two upcoming investor conferences.
